Vestal Point Capital, LP

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001974915
Type: FundHoldings: 63Value: $1.4BLatest: 2025Q1

Vestal Point Capital, LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 63 holdings worth $1.4 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
63
Total Value
1400316542
Accession Number
0001974915-25-000005
Form Type
13F-HR
Manager Name
Vestal-Point-Capital-Lp
Data Enrichment
97% identified
61 identified2 unidentified

Holdings

63 positions • $1.4B total value
Manager:
Search and click to pin securities to the top
Page 1 of 4
Arcellx, Inc.
Shares:2.4M
Value:$156.6M
% of Portfolio:11.2% ($156.6M/$1.4B)
CYTOKINETICS INC
Shares:2.6M
Value:$104.1M
% of Portfolio:7.4% ($104.1M/$1.4B)
INSMED Inc
Shares:1.1M
Value:$82.0M
% of Portfolio:5.9% ($82.0M/$1.4B)
Nuvalent, Inc.
Shares:1.1M
Value:$76.2M
% of Portfolio:5.4% ($76.2M/$1.4B)
Vera Therapeutics, Inc.
Shares:2.5M
Value:$60.0M
% of Portfolio:4.3% ($60.0M/$1.4B)
KalVista Pharmaceuticals, Inc.
Shares:4.8M
Value:$54.8M
% of Portfolio:3.9% ($54.8M/$1.4B)
uniQure N.V.
Shares:4.8M
Value:$50.8M
% of Portfolio:3.6% ($50.8M/$1.4B)
Crinetics Pharmaceuticals, Inc.
Shares:1.5M
Value:$50.3M
% of Portfolio:3.6% ($50.3M/$1.4B)
Xenon Pharmaceuticals Inc.
Shares:1.3M
Value:$43.6M
% of Portfolio:3.1% ($43.6M/$1.4B)
Scholar Rock Holding Corp
Shares:1.3M
Value:$41.8M
% of Portfolio:3.0% ($41.8M/$1.4B)
Bicara Therapeutics Inc.
Shares:2.8M
Value:$36.1M
% of Portfolio:2.6% ($36.1M/$1.4B)
GERON CORP
Shares:22.0M
Value:$35.0M
% of Portfolio:2.5% ($35.0M/$1.4B)
AMICUS THERAPEUTICS, INC.
Shares:4.3M
Value:$34.9M
% of Portfolio:2.5% ($34.9M/$1.4B)
Immatics N.V.
Shares:7.2M
Value:$32.4M
% of Portfolio:2.3% ($32.4M/$1.4B)
Structure Therapeutics Inc.
Shares:1.8M
Value:$31.0M
% of Portfolio:2.2% ($31.0M/$1.4B)
Dianthus Therapeutics, Inc. /DE/
Shares:1.7M
Value:$30.8M
% of Portfolio:2.2% ($30.8M/$1.4B)
Savara Inc
Shares:11.0M
Value:$30.5M
% of Portfolio:2.2% ($30.5M/$1.4B)
Tyra Biosciences, Inc.
Shares:2.9M
Value:$26.8M
% of Portfolio:1.9% ($26.8M/$1.4B)
DANAHER CORP /DE/
Shares:125.0K
Value:$25.6M
% of Portfolio:1.8% ($25.6M/$1.4B)
UroGen Pharma Ltd.
Shares:2.2M
Value:$23.8M
% of Portfolio:1.7% ($23.8M/$1.4B)